| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |